New EULAR criteria classify hand osteoarthritis phenotypes using radiographic features, enabling more targeted clinical trials for specific joint involvement patterns.
A systematic review of 439 studies reveals high-quality evidence supporting biologic therapies and defined treatment targets for systemic lupus erythematosus, with anifrolumab and belimumab showing superior efficacy to standard care in extrarenal disease.
EULAR's latest recommendations for systemic sclerosis treatment include 22 evidence-based guidelines across 8 clinical domains, marking a significant expansion from the 16 recommendations in 2017.
New HRS guidelines challenge traditional restrictions, revealing no increased arrhythmic risk for many athletes returning to play after proper evaluation and treatment.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.